Inventor
LIANG CHUNGEN
CN21 patents
⚠️ This page may combine multiple inventors who share the name “LIANG CHUNGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
19 patentsUS9458153B2Oct 4, 2016
Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE23 citations91
US10233184B2Mar 19, 2019
7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
HOFFMANN LA ROCHE12 citations83
US10336751B2Jul 2, 2019
Tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE3 citations72
US9949966B2Apr 24, 2018
Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE4 citations72
US9708325B2Jul 18, 2017
Sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
HOFFMANN LA ROCHE3 citations72
USRE49481EApr 4, 2023
Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
HOFFMANN LA ROCHE0 citations62
US8604019B2Dec 10, 2013
Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
HOFFMANN LA ROCHE2 citations62
US12060333B2Aug 13, 2024
Aminocarbamoyl compounds for the treatment of viral infections
HOFFMANN LA ROCHE1 citations61
US11242345B2Feb 8, 2022
Sulfonimidoylpurinone compounds and methods of treatment using the same
HOFFMANN LA ROCHE0 citations61
US11220502B2Jan 11, 2022
Sulfone compounds and derivatives for the treatment and prophylaxis of virus infection
HOFFMANN LA ROCHE0 citations61
US12012390B2Jun 18, 2024
Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease
HOFFMANN LA ROCHE0 citations52
US11993591B2May 28, 2024
Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease
HOFFMANN LA ROCHE0 citations52
US9790213B2Oct 17, 2017
Imidazoles for the treatment and prophylaxis of respiratory syncytial virus infection
HOFFMANN LA ROCHE0 citations52
US10752630B2Aug 25, 2020
7-substituted sulfonimidoylpurinone compounds for the treatment of virus infection
HOFFMANN LA ROCHE0 citations51
US10399983B2Sep 3, 2019
Sulfonimidoylpurinone compounds
HOFFMANN LA ROCHE0 citations51
US9902701B2Feb 27, 2018
Pyridazones and triazinones for treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE0 citations51
US7977372B2Jul 12, 2011
Ortho aminoamides for the treatment of cancer
HOFFMANN LA ROCHE0 citations49
US10189838B2Jan 29, 2019
Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
HOFFMANN LA ROCHE0 citations41
US9670211B2Jun 6, 2017
Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
HOFFMANN LA ROCHE0 citations41